Moreau, P., Pylypenko, H., Grosicki, S., Karamanesht, I., Leleu, X., Rekhtman, G., Masliak, Z., Robak, P., Esseltine, D.-L., Feng, H., Deraedt, W., van de Velde, H. and Arnulf, B. (2015) “Subcutaneous versus intravenous bortezomib in patients with relapsed multiple myeloma: subanalysis of patients with renal impairment in the phase III MMY-3021 study”, Haematologica. Pavia, Italy, 100(5), pp. e207-e210. doi: 10.3324/haematol.2014.118182.